Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro

BMC Anesthesiology

Volumn 4, Issue , 2004, Pages

  Scheinichen, Dirk ^a   Elsner, Holger Andreas ^a   Osorio, Rodin ^a   Jüttner, Björn ^a   Gröschel, Werner ^a   Jaeger, Karsten ^a   Piepenbrock, Siegfried ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Diclofenac; Flow cytometry; GPIIb IIIa; Metamizol; P selectin; Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLOOXYGENASE 1 INHIBITOR; DICLOFENAC; DIPYRONE; FIBRINOGEN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; CELL ASSAY; CELL SURFACE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LEUKOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 2942523003     PISSN: 14712253     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2253-4-4     Document Type: Article

References (28)

1. Peters MJ, Heyderman RS, Hatch DJ, Klein NJ: Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. J Immunol Meth 1997, 209:125-135.
2. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ: Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999, 106:391-399.
3. Cramer EM, Savidge GF, Vainchenker W, Berndt MC, Pidard D, Caen JP, Masse JM, Breton-Gorius J: Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes. Blood 1990, 75:1220-1227.
4. Liu YK, Nemoto A, Fang Y, Uemura T: The binding ability to matrix proteins and the inhibitory effects on cell adhesion of synthetic peptides derived from a conserved sequence of integrins. J Biochem 1997, 121:961-968.
5. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ: Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997, 23:379-385.
6. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor JL, de Gaetano G, Cerletti C: Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: Evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. Blood 1996, 88:4183-4194.
7. Vane JR: The mechanism of action of anti-inflammatory drugs. In Advances in eicosanoid research Edited by: Serhan CN, Perez HD. Berlin Heidelberg: Springer-Verlag; 2000:1-23.
8. Schafer AI: Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 1999, 106(Supl 5B):25S-35S.
9. Schmidt A, Bjorkman S, Akeson J: Preoperative rectal diclofenac versus paracetamol for tonsillectomy: effects on pain and blood loss. Acta Anaesthesiol Scand 2001, 45:48-52.
10. Perttunen K, Kalso E, Heinonen J, Salo J: IV diclofenac in post-thoracotomy pain. Br J Anaesth 1992, 68:474-480.
11. Laitinen J, Nuutinen LS, Puranen J, Ranta P, Salomaki T: Effect of a non-steroidal anti-inflammatory drug, diclofenac, on haemostasis in patients undergoing total hip replacement. Acta Anaesthesiol Scand 1992, 36:486-489.
12. Geisslinger G, Peskar BA, Pallapies D, Sittl R, Levy M, Brune K: The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone. Thromb Haemost 1996, 76:592-597.
13. Eldor A, Zylber-Katz E, Levy M: The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man. Eur J Clin Pharmacol 1984, 26:171-176.
14. Golanski J, Pietrucha T, Baj Z, Greger J, Watala C: Molecular insight into anticoagulant-induced spontaneous activation of platelets in whole blood: Various anticoagulants are not equal. Thromb Res 1996, 83:199-216.
15. Failli P, Cecchi E, Tosti-Guerra C, Mugelli A, Laffi G, Zilletti L, Giotti A: Effect of some cyclooxygenase inhibitors on the increase in guanosine 3′:5′-cyclic monophosphate induced by NO-donors in human whole platelets. Br J Pharmacol 1998, 123:1457-1463.
16. Van Hecken A, Schwartz JI, Depre M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ: Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol 2000, 40:1109-1120.
17. Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C: Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Physiol Pharmacol 1997, 48:623-631.
18. Bozzo J, Escolar G, Hernandez MR, Galan AM, Ordinas A: Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability. J Cardiovasc Pharmacol 2001, 38:183-190.
19. Abbate R, Pinto S, Gori AM, Paniccia R, Coppo M, Neri Serneri GG: Activity of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study. Pharmacological Research 1989, 21:43-50.
20. Holmsen H: Significance of testing platelet functions in vitro. Eur J Clin Invest 1994, 24(Suppl 1):3-8.
21. Cronberg S, Wallmark E, Soderberg I: Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol 1984, 33:155-159.
22. Eldor A, Polliack G, Vlodavsky I, Levy M: Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells. Thromb Haemostas 1983, 49:132-137.
23. Domínguez-Jiménez C, Díaz-González F, González-Álvaro I, Cesar JM, Sánchez-Madrid F: Prevention of αIIb_ab3 activation by non-steroidal anti-inflammatory drugs. FEBS Lett 1999, 446:318-322.
24. Andrioli G, Lussignoli S, Gaino S, Benoni G, Bellavite P: Study on paradoxical effects of NSAIDs on platelet activation. Inflammation 1997, 21:519-530.
25. Nyby MD, Sasaki M, Ideguchi Y, Wynne HE, Hori MT, Berger ME, Golub MS, Brickman AS, Tuck ML: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimeticinduced intracellular calcium mobilization and platelet aggregation. J Pharmacol Exp Ther 1996, 278:503-509.
26. Fonlupt P, Croset M, Lagarde M: 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res 1991, 63:239-248.
27. Cortelazzo S, Marchetti M, Orlando E, Falanga A, Barbui T, Buchanan MR: Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipoxygenase pathway. Am J Hematol 1998, 57:277-282.
28. Saeed SA, Afzal MN, Shah BH: Dual effects of nimesulide, a COX-2 inhibitor, in human platelets. Life Sciences 1998, 63:1835-1841.